EUGLYCAEMIC DIABETIC KETOACIDOSIS

This adverse event was reported 4133 times

EUGLYCAEMIC DIABETIC KETOACIDOSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 EMPAGLIFLOZIN 2079 0.0299
1 EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE 81 0.0275
2 EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE 87 0.0244
3 EMPAGLIFLOZIN AND LINAGLIPTIN 41 0.0209
4 ERTUGLIFLOZIN 21 0.0188
5 ERTUGLIFLOZIN AND SITAGLIPTIN 2 0.0167
6 EMPAGLIFLOZIN, LINAGLIPTIN, METFORMIN HYDROCHLORIDE 2 0.0161
7 COCAINE HYDROCHLORIDE NASAL 1 0.0154
8 OMIDENEPAG ISOPROPYL 1 0.0152
9 FAMOTIDINE 10 MG 1 0.0143
See all drugs enriched for association with EUGLYCAEMIC DIABETIC KETOACIDOSIS